Syngene International Limited's board approved the appointment of Mr. Vijaya Chandru and Mr. Arun Chandavarkar as Independent Directors for three-year terms starting July 2026. Additionally, Ms. Vinita Bali was appointed as a Non-Executive Director for a one-year term. These appointments bring significant expertise in biotechnology, AI, and global business leadership to the board.
Syngene International Limited has scheduled a Board Meeting on April 29, 2026, to consider audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also recommend a final dividend. Trading windows remain closed from April 1 until May 1, 2026.
Syngene International Ltd will hold a Board Meeting on April 29, 2026, to approve audited financial results for the quarter and year ending March 31, 2026. The board will also consider recommending a final dividend. Consequently, the trading window is closed from April 01 to May 01, 2026.
